These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29567089)

  • 1. An overview of the toxicities of checkpoint inhibitors in older patients with cancer.
    Alkharabsheh O; Kannarkatt P; Kannarkatt J; Karapetyan L; Laird-Fick HS; Al-Janadi A
    J Geriatr Oncol; 2018 Sep; 9(5):451-458. PubMed ID: 29567089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of immunotherapy in older adults: New treatments, new toxicities?
    Helissey C; Vicier C; Champiat S
    J Geriatr Oncol; 2016 Sep; 7(5):325-33. PubMed ID: 27318796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview.
    Plachouri KM; Vryzaki E; Georgiou S
    Curr Drug Saf; 2019; 14(1):14-20. PubMed ID: 30058498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges.
    Diesendruck Y; Benhar I
    Drug Resist Updat; 2017 Jan; 30():39-47. PubMed ID: 28363334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of immunotherapy toxicities in older adults.
    Bhandari S; Gill AS; Perez CA; Jain D
    Semin Oncol; 2018 Aug; 45(4):226-231. PubMed ID: 30446167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathways: Immune Checkpoint Antibodies and their Toxicities.
    Cousin S; Italiano A
    Clin Cancer Res; 2016 Sep; 22(18):4550-5. PubMed ID: 27435397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.
    Barroso-Sousa R; Ott PA; Hodi FS; Kaiser UB; Tolaney SM; Min L
    Cancer; 2018 Mar; 124(6):1111-1121. PubMed ID: 29313945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune checkpoint inhibitors and endocrinological side effects].
    Jørgensen LB; Bastholt L; Yderstræde K
    Ugeskr Laeger; 2017 Dec; 179(49):. PubMed ID: 29212592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects.
    Lombardi A; Mondelli MU
    Aliment Pharmacol Ther; 2019 Oct; 50(8):872-884. PubMed ID: 31378985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication use evaluation of programmed death-1 inhibitors in a veteran population.
    Nguyen V; Huq M
    J Oncol Pharm Pract; 2019 Jul; 25(5):1066-1075. PubMed ID: 29726785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.
    Sibaud V
    Am J Clin Dermatol; 2018 Jun; 19(3):345-361. PubMed ID: 29256113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Checkpoint inhibitors, the perspectives for elderly patients].
    Landre T; Karaoud F; Taleb C
    Soins Gerontol; 2017; 22(127):30-33. PubMed ID: 28917334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials.
    Kelly K; Infante JR; Taylor MH; Patel MR; Wong DJ; Iannotti N; Mehnert JM; Loos AH; Koch H; Speit I; Gulley JL
    Cancer; 2018 May; 124(9):2010-2017. PubMed ID: 29469949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity.
    Thompson JA
    J Natl Compr Canc Netw; 2018 May; 16(5S):594-596. PubMed ID: 29784734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
    Postow MA; Sidlow R; Hellmann MD
    N Engl J Med; 2018 Jan; 378(2):158-168. PubMed ID: 29320654
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.
    Sood A; Cole D; Abdollah F; Eilender B; Roumayah Z; Deebajah M; Dabaja A; Alanee S
    Curr Urol Rep; 2018 Jul; 19(9):68. PubMed ID: 29971696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy is cancer treatment with a novel side-effect profile].
    Kondrup M; Raunkilde L; Svane IM; Schmidt H; Bastholt L
    Ugeskr Laeger; 2017 Oct; 179(40):. PubMed ID: 28992844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avelumab: is it time to get excited?
    Marciscano AE; Gulley JL; Kaufman HL
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):815-821. PubMed ID: 29939083
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy and toxicity of immune checkpoint inhibitors in elderly patients - 5th edition of the congress of pharmacology of anticancer drugs].
    Gaultier De Saint Basile H; Poisson C; Arrondeau J; Boudou-Rouquette P; Goldwasser F; Tartour E; De Guillebon E
    Bull Cancer; 2018 Dec; 105(12):1202-1208. PubMed ID: 30471959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature.
    Chauhan A; Burkeen G; Houranieh J; Arnold S; Anthony L
    Ann Oncol; 2017 Aug; 28(8):2034-2038. PubMed ID: 28472223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.